By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Researchers at Jefferson Medical College has landed a $3 million grant from the National Institutes of Health to work study how expression of some genes can influence platelet function in the blood, such as clotting or bleeding, in order to develop better predictors of cardiovascular disease and potential therapeutic strategies.

The college, which is part of Thomas Jefferson University, will partner on the four-year research effort with Baylor College of Medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.